Royal Bank of Canada’s Acer Therapeutics Inc ACER Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-376
| Closed | – | – | 7862 |
|
|
2023
Q3 | $0 | Sell |
376
-306
| -45% | -$252 | ﹤0.01% | 7855 |
|
|
2023
Q2 | $1K | Buy |
+682
| New | +$604 | ﹤0.01% | 7166 |
|
|
2022
Q4 | – | Sell |
-13
| Closed | – | – | 7975 |
|
|
2022
Q3 | $0 | Buy |
+13
| New | +$19 | ﹤0.01% | 8071 |
|
|
2021
Q3 | – | Sell |
-100
| Closed | – | – | 7978 |
|
|
2021
Q2 | $0 | Hold |
100
| – | – | ﹤0.01% | 7783 |
|
|
2021
Q1 | $0 | Buy |
+100
| New | +$340 | ﹤0.01% | 7784 |
|
|
2020
Q4 | – | Sell |
-2,001
| Closed | -$6K | – | 7370 |
|
|
2020
Q3 | $6K | Sell |
2,001
-659
| -25% | -$2.13K | ﹤0.01% | 6108 |
|
|
2020
Q2 | $9K | Buy |
2,660
+1,615
| +155% | +$4.56K | ﹤0.01% | 5880 |
|
|
2020
Q1 | $2K | Buy |
1,045
+768
| +277% | +$2.81K | ﹤0.01% | 6353 |
|
|
2019
Q4 | $1K | Buy |
277
+248
| +855% | +$843 | ﹤0.01% | 6717 |
|
|
2019
Q3 | $0 | Sell |
29
-63
| -68% | -$185 | ﹤0.01% | 7259 |
|
|
2019
Q2 | $0 | Sell |
92
-1,204
| -93% | -$22.9K | ﹤0.01% | 7295 |
|
|
2019
Q1 | $31K | Buy |
+1,296
| New | +$30.6K | ﹤0.01% | 5432 |
|
|
2018
Q4 | – | Sell |
-5
| Closed | – | – | 7253 |
|
|
2018
Q3 | $0 | Buy |
+5
| New | +$134 | ﹤0.01% | 7042 |
|
|
2014
Q2 | – | Sell |
-1
| Closed | – | – | 6194 |
|
|
2014
Q1 | $0 | Buy |
+1
| New | +$152 | ﹤0.01% | 6206 |
|
Other funds holding ACER
Royal Bank of Canada's ACER Position: Q4 2023 in Review
Royal Bank of Canada sold out of Acer Therapeutics Inc (ACER) in Q4 2023, closing a stake of 376 shares.
Royal Bank of Canada first reported a position in ACER in Q1 2014 and held it in 14 quarters. The position peaked at $31K in Q1 2019. 2 funds tracked by Wall St. Rank hold ACER as of Q4 2023.
- Royal Bank of Canada reported no remaining Acer Therapeutics Inc position as of Q4 2023 after selling out during the quarter.
- Royal Bank of Canada sold 376 Acer Therapeutics Inc shares in Q4 2023.
- Royal Bank of Canada first reported a position in Acer Therapeutics Inc in Q1 2014 and held it in 14 quarters.
- Royal Bank of Canada's Acer Therapeutics Inc position peaked at $31K in Q1 2019.
- 2 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q4 2023.
Based on Royal Bank of Canada's 13F filing for Q4 2023, filed 14 Feb 2024.